The Chemours Company (/kɛˈmɔːrz/, kem-ORZ) is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CC | Chemours Co | 2026-04-02 18:37:23 | 21.68 | 0.13 | 0.6 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CC | 0001627223 | Chemours Co | US1638511089 | — | 464845564 | NYSE | 2800 | Chemicals & Allied Products | 1231 | DE | 1007 MARKET STREET | WILMINGTON | DE | 19801 | UNITED STATES | US | 302 773 1000 | 1007 MARKET STREET, WILMINGTON, DE, 19801 | 1007 MARKET STREET, WILMINGTON, DE, 19801 | Chemours Company, LLC | Chemical | 2015-07-01 | Denise Dignam | 6,000 | http://chemours.com | 1,700,000,000 | 198,720,786 | 150,085,308 | The Chemours Company (/kɛˈmɔːrz/, kem-ORZ) is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases. | 2026-04-02 16:40:07 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 1,700,000,000 | -1,700,000,000 | -50 | 150,085,308 | 644,520 | 0.4313 |
| 2024 | 3,400,000,000 | -2,100,000,000 | -38.1818 | 149,440,788 | 639,057 | 0.4295 |
| 2023 | 5,500,000,000 | 500,000,000 | 10 | 148,801,731 | 465,897 | 0.3141 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Joseph Martinko | President | 2025 | 542,123 | 0 | 425,281 | 301,568 | 32,327 | 1,668,707 |
| Shane Hostetter | Senior Vice President, Chief Financial Officer | 2025 | 646,767 | 0 | 864,868 | 472,388 | 15,000 | 2,746,166 |
| Denise Dignam | President, Chief Executive Officer | 2025 | 1,058,836 | 0 | 3,368,225 | 1,175,781 | 82,558 | 8,595,076 |
| Kristine Wellman | Senior Vice President, Corporate Secretary, General Counsel | 2025 | 591,918 | 0 | 499,500 | 384,300 | 51,570 | 1,958,806 |
| Gerardo Familiar | President | 2025 | 535,822 | 0 | 425,281 | 173,233 | 31,091 | 1,532,835 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 5,700 |
| 2024 | 6,000 |
| 2023 | 6,200 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 5,808,000,000 | 5,782,000,000 | 6,027,000,000 |
| Cost Of Revenue | 4,906,000,000 | 4,631,000,000 | 4,721,000,000 |
| Gross Profit | 902,000,000 | 1,151,000,000 | 1,306,000,000 |
| Research And Development Expenses | 108,000,000 | 109,000,000 | 108,000,000 |
| General And Administrative Expenses | 799,000,000 | 585,000,000 | 1,290,000,000 |
| Operating Expenses | 966,000,000 | 810,000,000 | 1,551,000,000 |
| Operating Income | — | — | — |
| Net Income | -386,000,000 | 86,000,000 | -238,000,000 |
| Earnings Per Share Basic | -2.57 | 0.58 | -1.6 |
| Earnings Per Share Diluted | -2.57 | 0.57 | -1.6 |
| Weighted Average Shares Outstanding Basic | 150,237,101 | 149,494,462 | 148,912,397 |
| Weighted Average Shares Outstanding Diluted | 150,237,101 | 150,172,289 | 148,912,397 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 670,000,000 | 713,000,000 | 1,203,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 679,000,000 | 770,000,000 | 610,000,000 |
| Inventories | 1,569,000,000 | 1,472,000,000 | 1,352,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 80,000,000 | 71,000,000 | 66,000,000 |
| Total Assets Current | 3,001,000,000 | 3,026,000,000 | 3,835,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 3,078,000,000 | 3,183,000,000 | 3,216,000,000 |
| Other Assets Non Current | 751,000,000 | 797,000,000 | 677,000,000 |
| Total Assets Non Current | 4,381,000,000 | 4,489,000,000 | 4,416,000,000 |
| Total Assets | 7,382,000,000 | 7,515,000,000 | 8,251,000,000 |
| Accounts Payable | 954,000,000 | 1,142,000,000 | 1,159,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 42,000,000 | 54,000,000 | 51,000,000 |
| Other Liabilities Current | 506,000,000 | 393,000,000 | 1,058,000,000 |
| Total Liabilities Current | 1,686,000,000 | 1,803,000,000 | 2,486,000,000 |
| Long Term Debt | 4,099,000,000 | 4,054,000,000 | 3,987,000,000 |
| Other Liabilities Non Current | 588,000,000 | 368,000,000 | 328,000,000 |
| Total Liabilities Non Current | 5,445,000,000 | 5,107,000,000 | 5,026,000,000 |
| Total Liabilities | 7,131,000,000 | 6,910,000,000 | 7,512,000,000 |
| Common Stock | 2,000,000 | 2,000,000 | 2,000,000 |
| Retained Earnings | 1,220,000,000 | 1,718,000,000 | 1,782,000,000 |
| Accumulated Other Comprehensive Income | -244,000,000 | -367,000,000 | -274,000,000 |
| Total Shareholders Equity | 250,000,000 | 604,000,000 | 737,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 340,000,000 | 301,000,000 | 307,000,000 |
| Share Based Compensation Expense | 21,000,000 | 15,000,000 | 18,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -106,000,000 | 152,000,000 | 10,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -165,000,000 | -9,000,000 | -72,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 264,000,000 | -633,000,000 | 556,000,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 213,000,000 | 360,000,000 | 370,000,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | -1,000,000 | -2,000,000 | -6,000,000 |
| Cash From Investing Activities | -206,000,000 | -353,000,000 | -229,000,000 |
| Tax Withholding For Share Based Compensation | 1,000,000 | 3,000,000 | 19,000,000 |
| Payments Of Dividends | 78,000,000 | 148,000,000 | 149,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 309,000,000 | 309,000,000 | 69,000,000 |
| Issuance Of Long Term Debt | 367,000,000 | 367,000,000 | 367,000,000 |
| Repayment Of Long Term Debt | 764,000,000 | 11,000,000 | 764,000,000 |
| Other Financing Activities | 21,000,000 | 21,000,000 | — |
| Cash From Financing Activities | -126,000,000 | -36,000,000 | 172,000,000 |
| Change In Cash | -39,000,000 | -1,044,000,000 | 503,000,000 |
| Cash At End Of Period | 670,000,000 | 713,000,000 | 1,203,000,000 |
| Income Taxes Paid | 74,000,000 | 73,000,000 | 54,000,000 |
| Interest Paid | 251,000,000 | 267,000,000 | 223,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -2.57 | 0.58 | -1.6 |
| Price To Earnings Ratio | -4.5875 | 29.1379 | -19.7125 |
| Earnings Growth Rate | -543.1034 | -136.25 | -143.0108 |
| Price Earnings To Growth Ratio | 0.0084 | -0.2139 | 0.1378 |
| Book Value Per Share | 1.6707 | 4.047 | 4.9626 |
| Price To Book Ratio | 7.057 | 4.176 | 6.3555 |
| Ebitda | 297,000,000 | 724,000,000 | 331,000,000 |
| Enterprise Value | 5,242,295,420.79 | 5,921,456,407.8 | 7,531,697,001.38 |
| Dividend Yield | 0.044 | 0.0586 | 0.0317 |
| Dividend Payout Ratio | -0.2021 | 1.7209 | -0.6261 |
| Debt To Equity Ratio | 16.564 | 6.8013 | 5.479 |
| Capital Expenditures | 235,000,000 | 268,000,000 | 352,000,000 |
| Free Cash Flow | 29,000,000 | -901,000,000 | 204,000,000 |
| Return On Equity | -1.544 | 0.1424 | -0.3229 |
| One Year Beta | 2.0787 | 1.4625 | 1.7456 |
| Three Year Beta | 1.853 | 1.4343 | 1.4357 |
| Five Year Beta | 1.5978 | 1.6441 | 1.7024 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| MATHER COURTNEY | Director | 2026-03-31 | 1,305 | A | 7,552 |
| Foley Michael Robert | — | 2026-03-02 | 25,013 | A | 28,513 |
| Foley Michael Robert | — | 2026-03-02 | 50,027 | A | 78,540 |
| Dignam Denise | Director, Chief Executive Officer | 2026-03-02 | 169,538 | A | 335,313 |
| Familiar Calderon Gerardo | — | 2026-03-02 | 25,708 | A | 57,292 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Tammy Duckworth | Senator | 2017-11-07 | Sale (Full) | 2017-10-10 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Michael C. Burgess | 2023-09-05 | TX26 | Purchase | 2023-08-09 | — | $15,001 - $50,000 |
| Michael C. Burgess | 2023-07-18 | TX26 | Purchase | 2023-07-06 | Spouse | $15,001 - $50,000 |
| Michael C. Burgess | 2023-07-18 | TX26 | Sale (Partial) | 2023-07-06 | Spouse | $1,001 - $15,000 |
| Richard L. Hanna | 2015-11-09 | NY22 | Sale | 2015-10-01 | — | $1,001 - $15,000 |
| Richard L. Hanna | 2015-08-13 | NY22 | Exchange | 2015-06-30 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Coastline Trust Co | 2026-03-31 | 69,395 | 3,150 | 22.0302 |
| Investors Research Corp | 2026-03-31 | 506,580 | 22,995 | 22.03 |
| Ares Financial Consulting, LLC | 2026-03-31 | 1,291 | 60 | 21.5167 |
| Hilltop National Bank | 2026-03-31 | 5,045 | 229 | 22.0306 |
| Bangor Savings Bank | 2026-03-31 | 771 | 35 | 22.0286 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-01-31 | Global X Russell 2000 ETF | RSSL | 68,144 | 1,021,478.56 | 0.0737 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-01-31 | Invesco RAFI US 1000 ETF | PRF | 133,819 | 2,005,946.81 | 0.0226 |
| Catholic Responsible Investments Funds | 2026-01-31 | Institutional Shares | CRSSX | 60,224 | 902,757.76 | 0.1539 |
| VANGUARD EXPLORER FUND | 2026-01-31 | Admiral Shares | VEXRX | 176,879 | 2,651,416.21 | 0.0128 |
| VANGUARD EXPLORER FUND | 2026-01-31 | Investor Shares | VEXPX | 176,879 | 2,651,416.21 | 0.0128 |